UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
MATRIX PHARMACEUTICAL, INC.
-----------------------------------------------------------------
(Name of Issuer)
Common Stock
-----------------------------------------------------------------
(Title of Class of Securities)
576844104
--------------------
(CUSIP Number)
December 31, 1998
----------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/ X / Rule 13d-1(b)
/ / Rule 13d-1(c)
/ / Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of the section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13G
CUSIP NO. 576844104
1. Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Quaker Capital Management Corporation
------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group
(a)
-----
(b) X
-----
3. SEC Use Only
---------------------------------------------
4. Citizenship or Place of Organization Pennsylvania
---------------
Number of 5. Sole Voting Power 892,500
Shares ---------------
Beneficially 6. Shared Voting Power 1,435,300
Owned by ---------------
Each Reporting 7. Sole Dispositive Power 892,500
Person With: ---------------
8. Shared Dispositive Power 1,435,300
---------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,327,800
---------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
--------
The Reporting Person disclaims beneficial ownership of
2,317,300 shares owned by its clients.
11. Percent of Class Represented by Amount in Row (9) 10.53%
--------------
12. Type of Reporting Person IA
--------------
Page 2 of 4 Pages
<PAGE>
SCHEDULE 13G
CUSIP NO. 576844104
This constitutes Amendment No. 1 to the Schedule 13G of Quaker Capital
Management Corporation filed with the Securities and Exchange Commission on
December 15, 1998 relating to the Common Stock of Matrix Pharmaceutical,
Inc.(the "Schedule 13G").
Item 4 of the Schedule 13G is hereby amended and restated to read as follows:
Item 4. Ownership
---------
(a) The Reporting Person, in its capacity as investment adviser, may be
deemed to be the beneficial owner of 2,317,300 shares of the Common
Stock of the Issuer which are owned by various investment advisory
clients of the Reporting Person in accounts over which the Reporting
Person has discretionary authority. The filing of this report shall
not be construed as an admission that the Reporting Person is, for
purposes of Section 13(d) or 13(g) of the Act, the beneficial owner
of these securities. Additionally, the Reporting Person and/or its
principals own 10,500 shares of the Common Stock of the Issuer.
(b) The shares covered by this report represent 10.53% of the Common
Stock of the Issuer.
(c) None of the clients of the Reporting Person is known to own more
than 5% of the Common Stock of the Issuer. The Reporting Person has
shared voting and dispositive power over 1,435,300 shares and sole
voting and dispositive power over 882,000 shares owned by its
clients and held in accounts over which it has discretionary
authority. The Reporting Person and/or its principals have sole
voting and dispositive power over the 10,500 shares owned by the
Reporting Person and/or its principals.
Item 6 of the Schedule 13G is hereby amended and restated to read as follows:
Item 6. Ownership of More than Five Percent on
Behalf of Another Person
---------------------------------------
2,317,300 of the shares with respect to which this report is filed
are owned by a variety of investment advisory clients of the
Reporting Person, which clients
Page 3 of 4 Pages
<PAGE>
SCHEDULE 13G
CUSIP NO. 576844104
are entitled to receive dividends on and the proceeds from the sale
of such shares. No client is known to own more than 5% of the class.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
February 14, 1999
---------------------------------
Date
/s/ Mark G. Schoeppner, President
---------------------------------
Signature
Mark G. Schoeppner, President
---------------------------------
Name/Title
Page 4 of 4 Pages
